Search results for " host cell"

Article A Risk-Based Genetic Characterization Strategy for Recombinant CHO Cell Lines Used for Clinical and Commercial Applications
The authors describe the ways in which manufacturers can mitigate the risks related to the integrity of recombinant transgenes expressed in CHO cells. By Luhong He, Christopher Frye Abstract …

Article The Evolving Role of Starting Materials in Cell and Gene Therapy
The Evolving Role of Starting Materials in Cell and Gene Therapy Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting m…

Article Best Practices for Selecting a Top-Quality Cell Line
“The ability to sequence the host cell-line genome, and more recently the transcriptome, along with the development of the bioinformatics to analyze that data has allowed for significant advances in c…

Article Commercial Production of Gene Therapies Using Suspension or Adherent Cell Lines
This article will explore the traditional path from the laboratory to the clinic and how the fixed-bed technology provides an alternative solution to meet commercial demands. By Alex Chatel and …

Article Implications of Cell Culture Conditions on Protein Glycosylation
The choice of host cell and the bioreactor conditions used in bioproduction of proteins significantly affects protein product quality. This is due both to the structural complexity of proteins themsel…

Article Challenging Host Cell Protein Assays for Improved Risk Mitigation
Click here to learn more >> This webinar shares Cytiva’s strategy for designing a comprehensive host cell protein (HCP) risk mitigation strategy. We will address how to challenge your assays ea…

Article Impact of Media Components on CQAs of Monoclonal Antibodies
Future Perspective Progress in cell-culture technology has led to substantial enhancement in production of recombinant protein products mostly due to robust vector design and host cell engineering …

Article Antibody Production in Microbial Hosts
Absence of post-translational modifications in bacterial host cells leads to a complete abolition of glycosylation of antibodies, resulting in structural changes such as open conformation, enhanced fl…

Article Host-Cell Protein Measurement and Control
Recombinant therapeutic proteins are usually produced by genetically-modified prokaryotic or eukaryotic host cells using cell culture/fermentation technology (2). Genetic engineering allows the host c…

Article Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
Impurities originating from the host cells were removed during the downstream process. Cell debris was removed in the first microfiltration step using ULTA Prime GF 2 μm and 0.6 μm normal flow filters…

Next Page